Gates Foundation grants $826K to Mass. biotech

04/4/2013 | American City Business Journals

The Bill & Melinda Gates Foundation, through its Grand Challenges Explorations initiative, awarded Tetragenetics a Phase II grant worth $826,000 to develop a more effective oral vaccine for malaria. The grant builds on a 2009 Phase I grant.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC